Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

[esc](/topic/esc)

### Sentiment: XX%
![Sentiment Line Chart](https://lunarcrush.com/gi/w:600/t:esc/c:line/m:sentiment/iv:1d.svg)  
[Sentiment 24-Hour Time-Series Raw Data](/topic/esc/time-series/sentiment.tsv)  
**Current Value**: XX%  
**Daily Average**: XX%  
**1 Week**: XX% -X%  
**1 Month**: XX% -XX%  
**6 Months**: XX% +6%  
**1 Year**: XX% -X%  
**1-Year High**: XX% on 2025-07-19  
**1-Year Low**: XX% on 2025-02-08  

**Most Supportive Themes**
- **Cardiovascular Health Advancements:** (35%) Posts discussing advancements and innovations in cardiovascular care, including data from the ESC Congress 2025.
- **Cytokinetics Data:** (25%) Positive data from Cytokinetics (CYTK) regarding Aficamten in multiple clinical trials presented at ESC Congress 2025.
- **Novo Nordisk's STEER Study:** (20%) Data from Novo Nordisk's STEER study showing Wegovy's effectiveness in reducing cardiovascular risk.
  
**Most Critical Themes**
- **Slovenia and Israel's Participation:** (10%)  Concerns and potential non-participation of Slovenia in Eurovision 2026 if Israel participates.
  
Network engagement breakdown:  
| Network | Positive | %    | Neutral | %    | Negative | %    |
| ------- | -------- | -    | ------- | -    | -------- | -    |
|         |          |      |         |      |          |      |
| Total   | X        | NaN% | X       | NaN% | X        | NaN% |

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

esc

Sentiment: XX%

Sentiment Line Chart
Sentiment 24-Hour Time-Series Raw Data
Current Value: XX%
Daily Average: XX%
1 Week: XX% -X%
1 Month: XX% -XX%
6 Months: XX% +6%
1 Year: XX% -X%
1-Year High: XX% on 2025-07-19
1-Year Low: XX% on 2025-02-08

Most Supportive Themes

  • Cardiovascular Health Advancements: (35%) Posts discussing advancements and innovations in cardiovascular care, including data from the ESC Congress 2025.
  • Cytokinetics Data: (25%) Positive data from Cytokinetics (CYTK) regarding Aficamten in multiple clinical trials presented at ESC Congress 2025.
  • Novo Nordisk's STEER Study: (20%) Data from Novo Nordisk's STEER study showing Wegovy's effectiveness in reducing cardiovascular risk.

Most Critical Themes

  • Slovenia and Israel's Participation: (10%) Concerns and potential non-participation of Slovenia in Eurovision 2026 if Israel participates.

Network engagement breakdown:

Network Positive % Neutral % Negative %
Total X NaN% X NaN% X NaN%
esc Sentiment
/topic/esc/sentiment